A 35-year-old man presents to the outpatient clinic with chronic, intermittent joint pain, fatigue, and a mild photosensitive rash. Based on the clinical presentation and demographics, the physician estimates the patient's pre-test probability of a novel systemic autoimmune syndrome to be . To further evaluate, the physician utilizes a newly validated two-step serological testing algorithm. First, a screening enzyme-linked immunosorbent assay (ELISA) is performed. This test has a sensitivity of and a specificity of . The patient's ELISA result is positive. Next, a confirmatory immunoblot assay is performed. This test has a sensitivity of and a specificity of . The patient's immunoblot result is negative. Assuming the performance characteristics of the two assays are statistically independent, which of the following is the patient's post-test probability of having the systemic autoimmune syndrome?
- A
- Answer
- C
- D
- E